SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 111 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,955 | +10.5% | 51,402 | +24.5% | 0.00% | – |
| Q2 2023 | $330,296 | 0.0% | 41,287 | 0.0% | 0.00% | – |
| Q1 2023 | $330,296 | +2.0% | 41,287 | +15.4% | 0.00% | – |
| Q4 2022 | $323,801 | -99.7% | 35,779 | +128.9% | 0.00% | – |
| Q3 2022 | $108,344,000 | +26.2% | 15,634 | 0.0% | 0.00% | – |
| Q2 2022 | $85,831,000 | -57.4% | 15,634 | 0.0% | 0.00% | – |
| Q1 2022 | $201,522,000 | -67.4% | 15,634 | -37.1% | 0.00% | – |
| Q4 2021 | $617,845,000 | +11.8% | 24,873 | +48.6% | 0.00% | – |
| Q3 2021 | $552,722,000 | +14.3% | 16,739 | 0.0% | 0.00% | – |
| Q2 2021 | $483,757,000 | -37.3% | 16,739 | +9.9% | 0.00% | – |
| Q1 2021 | $771,704,000 | -3.8% | 15,233 | -7.8% | 0.00% | – |
| Q4 2020 | $802,201,000 | +264.8% | 16,530 | +33.0% | 0.00% | – |
| Q3 2020 | $219,887,000 | – | 12,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |